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Summary A medical record-based study of leukaemia and non-Hodgkin's lymphoma diagnosed before the age of 30 years was carried out
at three hospitals in the south of England. Findings for 177 cases and 354 age- and sex-matched controls are presented here. For
documented viral infection in pregnancy, the odds ratio (OR) was 6.0 [95% confidence interval (Cl) 1.2-29.7] for leukaemia and infinity (95%
Cl 1.2-) for non-Hodgkin's lymphoma. Mothers of leukaemic cases were more likely to be anaemic, the OR for a pregnancy haemoglobin
below 10g being 3.8 (95% Cl 1.3-11.1). An association with birthweight was found for acute myeloid leukaemia, the OR for birthweights
> 3500 g being 6.2 (95% Cl 1.3-29.8). Further, the preceding siblings of those diagnosed with any form of leukaemia were also more likely to
weigh > 3500 g at birth (OR 2.2; 95% Cl 1.1-4.4). Overall, leukaemic cases appeared to be comparatively robust at birth with respect to other
indicators ofwell-being, the ORs forjaundice, phototherapy, admission to special care nursery and neonatal intensive care all being less than
1.0. Further, no relation between childhood leukaemia and neonatal administration of intramuscular vitamin K was noted (OR 0.6, 95% Cl
0.3-1.4; for acute lymphoblastic leukaemia diagnosed between the ages of 1 and 6 years).
Keywords: childhood cancer; non-Hodgkin's lymphoma; leukaemia; in utero exposure
Epidemiological evidence that in utero exposures could be an
important determinant ofchildhood malignancy was firstprovided
by the Oxford Survey of Childhood Cancers over 40 years ago,
when an association between abdominal radiography of mothers
during pregnancy was related to the subsequent development of
leukaemia and other cancers in their children (Stewart et al, 1956,
1958). While this association was initially greeted with some scep-
ticism, it is now generally accepted that the fetus and the young
child may be more susceptible to the effects of ionizing radiation
than the adult. Modem concern revolves mainly around the impor-
tance of the magnitude of the dose and the gestational age at the
time ofexposure (Doll, 1973; Bithell and Stiller, 1988; Gilman et
al, 1988; Mole, 1990; Wakeford, 1995).
Interest in the potential carcinogenic effects of in utero expo-
sures was rekindled in 1971 when Herbst and colleagues reported
a striking association between the development of adenocarci-
noma of the vagina in young women and their mothers' use of
diethylstilboestrol in pregnancy. Since then, an ever-lengthening
list of prenatal and neonatal factors have been suggested as
possible risk factors for cancer in general, and for leukaemia in
particular, although much of the evidence for such associations is
sparse or contradictory. Recently, however, although no candidate
exposures were identified, Ford and colleagues (1993) provided
molecular evidence that rearrangements of the gene at 11q23 seen
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in the majority of infant leukaemias could originate in utero; and
in a further report they suggested that T-lineage malignancies in
older children could also be initiated in utero (Ford et al, 1997).
We describe here the main findings from a medical record-based
case-control study of leukaemia and non-Hodgkin's lymphoma
diagnosed in individuals before their 30th birthday who were born
at one of three hospitals in the South of England. This study was
specifically designed to examine the relation between disease and a
range ofprenatal and neonatal factors and exposures. Preliminary
results concerning the association between leukaemia diagnosed
before the age of 15 years and the administration ofintramuscular
vitamin K have already been published (Ansell et al, 1996).
DATA AND METHODS
Cases comprise individuals diagnosed with leukaemia or non-
Hodgkin's lymphoma in the UK between the ages of 3 months and
29 years whose mother's obstetric notes were stored at one ofthree
hospitals: the John Radcliffe (Oxford), the Rosie Maternity
(Cambridge) orthe Royal Berkshire (Reading). Good-quality histor-
ical maternity records were available in a readily accessible form in
allthreehospitals, theobstetric notes ofwomen delivering within the
catchment area ofthe study hospitals (or their predecessors) having
been routinely kept in paper or microfilm form in Cambridge,
Oxford and Reading from 1956, 1938 and 1969 respectively.
Cases were identified from two sources: children (0-14 years)
diagnosed between 1962 and 1992 from the Childhood Cancer
Research Group (Stiller et al, 1995) and young adults (15-29 years)
diagnosed between 1972 and 1987 from routine cancer registra-
tions compiled by the Office of National Statistics (ONS). In both
406Pre- andneonatal factors in leukaemia andNHL 407
Table 1 Numbers of cases and their corresponding controls distributed by study hospital and success in locating and abstracting delivery and obstetric notes
Cambridgea (%) Oxfordb (%) Readingc (%) Total (%)
Cases
Registered with leukaemia or non-Hodgkin's lymphoma 75 (100) 75 (100) 67 (100) 217 (100)
Delivery record abstracted 62 (82.7) 72 (96.0) 62 (92.5) 196 (90.3)
Obstetric notes abstracted 61 (81.3) 66 (88.0) 57 (85.1) 184 (84.8)
Controls available foranalysis
Total 122 (100) 132 (100) 114 (100) 368 (100)
First choice 119 (97.5) 111 (84.1) 107 (93.9) 337 (91.6)
Replacements 3 (2.5) 21 (15.9) 7 (6.1) 31 (8.4)
aRosie Maternity Unit (predecessor Mill Road Hospital), born 1956 or later; bJohn Radcliffe (predecessors Churchill Hospital and Nuffield Matemity Unit), born
1948 or later; cRoyal Berkshire, born 1969 or later.
Table 2 Characteristics of individuals registered with leukaemia or non-Hodgkin's lymphoma before 30 years of age whose obstetric notes were abstracted and
who were included in the analysisa
Leukaemia
Total leukaemiab n (%) Acute lymphoblastic n (%) Acute myeloid n (%) Non-Hodgkin's lymphoma n (%)
Number available for analysis 150 115 16 34
Number included in the analysisa 143 (100) 113 (100) 15 (100) 34 (100)
Sex
Male 79 (55.2) 63 (55.8) 6 (40.0) 20 (58.8)
Female 64 (44.8) 50 (44.2) 9 (60.0) 14 (41.2)
Age at diagnosis (years)
< 1 11 (7.7) 7 (6.2) 0 (0.0) 2 (5.9)
1-4 66 (46.2) 58 (51.3) 4 (26.7) 6 (17.6)
5-9 39 (27.3) 31 (27.4) 2 (13.3) 8 (23.5)
10-14 16 (11.2) 13 (11.5) 3 (20.0) 6 (17.6)
15-19 6 (4.2) 3 (2.7) 3 (20.0) 4 (11.8)
>20 5(3.5) 1 (0.1) 3(20.0) 8(23.5)
Year of diagnosis
< 1970 16(11.2) 8(7.1) 2 (13.3) 2 (5.9)
1970-74 20 (14.0) 16 (14.2) 1 (6.7) 7 (20.6)
1975-79 33 (23.1) 29 (25.7) 2 (13.3) 3 (8.8)
1980-84 45 (31.5) 38 (33.6) 5 (33.3) 9 (26.5)
1985-89 19(13.3) 12 (10.6) 5 (33.3) 11 (32.3)
>1990 10(7.0) 10(8.8) 0 (0.0) 2 (5.9)
Year of birth
< 1954 3 (2.1) 0 (0.0) 2 (13.3) 1 (2.9)
1955-59 10 (7.0) 7 (6.2) 1 (6.7) 6 (17.6)
1960-64 15(10.5) 8(7.1) 4 (26.7) 6 (17.6)
1965-69 14 (9.8) 12 (10.6) 1 (6.7) 5 (14.7)
1970-74 40 (28.0) 35 (31.0) 3 (20.0) 5 (14.7)
1975-79 28 (19.6) 23 (20.4) 2 (13.3) 4 (11.8)
1980-84 19(13.3) 15(13.3) 1 (6.7) 5 (14.7)
>1985 14(9.8) 13(11.5) 1 (6.7) 2 (5.9)
aSeven children with trisomies (six Down's and one Edward's) are excluded from the analysis presented here; bincludes fifteen individuals with 'other' and
'unspecified' diagnoses.
instances, individuals born within the catchment areas ofthe study
hospitals were identified by their National Health Service (NHS)
number, which is a cipher containing information about place and
date of birth. (NHS numbers having recently been appended to
large numbers ofroutinely compiled cancerregistrations.)
The date of birth and surname at cancer registration of persons
identified as having been born within the catchment areas of the
study hospitals were used to locate the delivery register entry of
the individual's birth, and the information recorded there was in
turnused to trace their mothers' obstetric notes. Locating delivery
records of cases was not always straightforward, for two main
reasons. Firstly, an individual's name at cancer registration was
not necessarily the same as their mother's surname at the time of
their birth. Secondly, hospital procedures vary with respect to the
number of delivery registers current at any one time; sometimes
differentregisters are used by different staffor in different circum-
stances (e.g. instrumental deliveries, midwives, general practi-
tioners, home births etc.). When the delivery register entry could
not be found, the National Health Services Central Register
(NHSCR) in Southport was approached and asked to check that
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Table 3 Characteristics of mothers of cases and their matched controls
Leukaemia
Total leukaemia Acute lymphoblastic Acute myeloid Non-Hodgkin's lymphoma
Number
Cases 143 113 15 34
Controls 286 226 30 68
Age at index birth (mean years ± s.e.)
Cases 27.2 ± 0.42 27.2 ± 0.47 28.5 ± 1.22 25.9 ± 1.13
Controls 27.0 ± 0.32 26.8 ± 0.35 26.0 ± 0.92 26.3 ± 0.62
Height (mean cm ± s.e.)
Cases 161.5 ± 0.58 161.4± 0.61 163.8± 2.29 161.0± 1.29
Controls 161.7 ±0.42 161.9 ±0.47 161.0 ± 1.48 161.7 ± 0.97
Previous pregnancies (mean per
women ± s.e.)
Total pregnancies
Cases 1.1 ±0.11 1.0±0.12 2.0+0.48 1.0±0.24
Controls 1.3 ± 0.09 1.2 ± 0.10 1.2 ± 0.27 1.1 ± 0.18
Fetal deathsa
Cases 0.3 ± 0.06 0.3 ± 0.06 0.4 ± 0.21 0.2 ± 0.06
Controls 0.3± 0.04 0.3± 0.05 0.3± 0.14 0.3+ 0.08
Infertility (% ± s.e.)
Ever investigated
Cases 9.1 ±2.40 7.1 ±2.41 6.7± 6.44 0.00
Controls 4.6 ± 1.23 4.4 ± 1.37 6.7 ± 4.55 5.9 ± 2.85
Ever treated
Cases 4.9 ± 1.80 3.5± 1.74 0.00 0.00
Controls 2.4 ± 0.91 2.7± 1.07 3.3 + 3.28 1.5 ± 1.46
aMiscarriage and stillbirths combined.
Table 4 Number of mothers of leukaemia cases and controls, and odds
ratios (95% confidence interval)a investigated and treated for infertility before
the index pregnancy
Cases Controls OR (95% Cl)
Investigated
Ever 13 13 2.1 (0.9-4.6)
Treated
Ever 7 7 2.1 (0.7-6.4)
Hormonally 5 4 2.5 (0.7-9.3)
For index 5 5 2.0 (0.6-6.9)
Hormonally 4 3 2.7 (0.6-11.9)
aEstimated using informative matched sets.
the information held by us was correct and also to provide addi-
tional details about any differences between the individual's
surname at cancer registration and their mother's surname at the
time oftheir birth.
For each case whose mother's obstetric notes were located, two
controls (matched on hospital catchment area ofbirth, sex and year
and month of birth) were selected from delivery registers held at
the study hospitals. Controls were chosen by generating two
random times (day/hour/minute) within the month of birth of the
case and by searching through all available delivery registers to
identify the two babies who were born closest to those times. As
for cases, information recorded in the delivery register was then
used to locate obstetric notes. When the obstetric notes ofacontrol
identified from the delivery registers could not be found, a further
day/time was generated and a replacement control was selected.
Cases and controls who, on inspection of the notes, were found
to be members of a multiple pregnancy or who had died before
discharge from hospital were considered ineligible. Babies with
identifiable chromosomal anomalies (e.g. Down's syndrome) or
other severe malformations (e.g. spina bifida) were excluded from
the pool ofpotential controls, and cases with such conditions were
subsequently excluded from the analyses presented here.
Information on our success in finding delivery records, obstetric
notes of cases and obstetric notes of controls identified from the
delivery registers is given in Table 1. Overall, delivery records of
196 (90.3%) and maternal obstetric notes of 184 (84.8%) of the
217 cases identified by their NHS number as having been born
within the catchment areas of the study hospitals were found.
Three hundred and thirty-seven (91.6%) ofthe 368 controls avail-
able for the analysis (two for each of the 184 cases with obstetric
abstractions) were first-choice selections from the delivery regis-
ters and 31 (8.4%) were replacements.
Delivery details, maternal obstetric notes and, when the child
was admitted to a special care nursery, neonatal notes and informa-
tion contained within the nursing cardex were abstracted by expe-
rienced research nurses (three midwives and one paediatric nurse)
using structured forms and coding procedures specially designed
by us to be applicable in a variety ofsettings. As well as informa-
tion recorded in medical notes, historical details about each
hospital's vitamin K policy were also sought from current hospital
staff. Data were entered onto computer, checked and subsequently
analysed using standard statistical techniques (Breslow and Day,
1980) and computer software (SPSS, 1989; Epicure, 1993; Stata,
1995). Relative risks were estimated as matched odds ratios using
conditional logistic regression. Two-sided P-values and 95%
confidence intervals (95% CI) are presented throughout.
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Table 5 Numbers of cases, controls and odds ratios (95% confidence interval)a by selected delivery and infant characteristics
Leukaemia
Total leukaemia Acute lymphoblastic Acute myeloid Non-Hodgkin's lymphoma
Cases/controls OR (95% Cl) Cases/controls OR (95% Cl) Cases/controls OR (95% Cl) Cases/controls OR (95% Cl)
Total presentation 143/286 113/226 15/30 34/68
Non-cephalic 6/9 1.3 (0.5-3.7) 6/6 2.0 (0.6-6.2) 0/1 0.0 (0.0-11.7) 4/1 8.0 (0.9-71.6)
Delivery
Caesarean 15/24 1.3 (0.6-2.5) 13/19 1.4 (0.7-3.0) 2/0 oo(1.2-2) 5/9 1.1 (0.3-3.7)
Drugs in labour
General anaesthetic 13/25 1.0 (0.5-2.1) 11/20 1.1 (0.5-2.4) 1/1 °° (0.1-00) 5/8 1.3 (0.4-3.8)
Local anaesthetic 44/81 1.1 (0.7-1.8) 35/66 1.1 (0.7-1.9) 4/6 1.5 (0.3-7.5) 5/14 0.6 (0.2-2.1)
Entonox 47/108 0.8 (0.5-1.2) 29/78 0.6 (0.3-1.0) 10/18 1.7 (0.3-10.1) 13/32 0.6 (0.2-1.6)
Opioids 79/163 0.9 (0.6-1.4) 57/123 0.8 (0.5-1.3) 9/21 0.6 (0.2-2.4) 22/37 1.6 (0.7-3.7)
Pethidine 72/138 1.1 (0.7-1.6) 55/106 1.1 (0.7-1.7) 7/14 1.0(0.3-3.5) 21/33 1.8 (0.7-4.2)
Jaundice
Diagnosed 21/49 0.8 (0.5-1.5) 19/41 0.9 (0.5-1.7) 1/1 2.0 (0.1-32.0) 8/6 3.4 (0.8-13.6)
Given phototherapy 2/8 0.5 (0.1-2.3) 2/6 0.6 (0.1-3.4) 0/1 0.0 (0.0-11.7) 1/0 oo (0.3-)
Special care nursery
Admitted 21/43 0.9 (0.5-1.7) 19/37 1.0 (0.5-1.9) 1/3 0.6 (0.0-7.4) 6/5 3.0 (0.8-10.6)
Neonatal intensive care 3/9 0.6 (0.2-2.5) 3/8 0.7 (0.2-2.9) 0/0 - 1/1 2.0 (0.1-32.0)
Intramuscular vitamin K
'Yes' recorded in notes 89/172 1.2 (0.7-2.1) 74/146 1.1 (0.6-2.0) 6/14 0.4 (0.0-4.4) 22/39 1.7 (0.5-5.5)
'Yes' imputedb 105/207 1.2 (0.5-2.4) 88/177 0.9 (0.4-2.2) 7/15 0.0 (0.0-11.7) 25/49 1.2 (0.3-5.2)
Birth weight
<2500g 6/11 1.1 (0.4-2.9) 6/9 1.3 (0.5-3.7) 0/1 0.0 (0.0-11.7) 4/4 2.3(0.5-10.4)
> 3500 g 56/100 1.2 (0.8-1.8) 41/85 0.9 (0.6-1.5) 9/6 6.2 (1.3-29.8) 9/31 0.4 (0.2-1.1)
aEstimated using informative matched sets. bimputed from information about hospital policy, a 'Yes' or 'No' in hospital notes taking prionty over imputation.
Table 6 Numbers of cases, controls and odds ratios (95% confidence intervals)a for Non-Hodgkin's lymphoma by selected delivery and infant characteristics
Odds ratio (95% Cl)
Cases Controls Crude Adjustedb
Total 34 68
Non-cephalic presentation 4 1 8.0 (0.9-71.6) 5.7 (0.6-56.6)
Jaundice diagnosed 8 6 3.4 (0.8-13.6) 2.1 (0.4-10.6)
Low birthweight 4 4 2.3 (0.5-10.4) 2.6 (0.4-16.4)
Admitted to special care nursery 6 5 3.0 (0.8-10.6) 1.0 (0.2-5.4)
aEstimated using informative matched sets. bEach odds ratio is adjusted for the potential effects ofthe other three factors in the table.
RESULTS
The characteristics of cases included in the analyses are shown by
diagnosis in Table 2. As the association between Down's
syndrome and leukaemia is well documented and as Down's
syndrome babies have more perinatal problems than other babies,
the seven trisomic cases (six Down's and one Edward's) are
excluded from the analyses presented here. No other serious
malformations wererecorded in the notes ofthe cases. The sex and
age distributions of the remaining 177 reflect those normally
observed among young people diagnosed with a haematological
malignancy: 79 (55%) of the 143 individuals with leukaemia and
20 (59%) ofthe 34 with non-Hodgkin's lymphoma were male; and
77 (54%) of the leukaemic cases compared with eight (23%) of
those with non-Hodgkin's lymphoma were diagnosed before the
age of 5 years. The majority of the results that follow relate to all
age groups combined. All analyses were, however, repeated for
finer age groupings (0-4, 5-9, 10-14 and 2 15 years) and, when
informative, age-specific results are also presented.
There are no statistically significant differences between cases
and their corresponding controls with respect to the maternal vari-
ables listed in Table 3. For the leukaemias, however, the marginal
differences between cases and controls with respect tomaternal age
and numbers ofprevious pregnancies may be worth noting as both
are in directions that have been reported before - leukaemic case
mothers being, on average, slightly older and having fewer past
pregnancies. Nonetheless, there is little support for the hypothesis
that leukaemia is more common among individuals who have no
older brothers or sisters: the odds ratios for first live-born child
being 1.0 (95% confidence interval 0.6-1.5), 0.9 (95% CI 0.6-1.5)
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Table 7 Birthweight of index babies by age at diagnosis and birthweights of their immediately preceding siblings: numbers of
babies and odds ratios (95% confidence interval)a with birthweights more than 3500 g
Leukaemia
Total Acute lymphoblastic Acute myeloid
Case/controls OR (95% Cl) Case/controls OR (95% Cl) Case/controls OR (95% Cl)
Age of case at diagnosis (years)
0-4 24/60 0.7 (0.4-1.3) 20/53 0.6 (0.3-1.2) 2/2 - (0.3-)
5-9 19/27 1.7 (0.8-3.7) 14/22 1.4 (0.6-3.2) 2/1 - (0.7-)
10-14 7/7 2.3 (0.7-7.5) 5/6 1.9 (0.5-7.4) 2/1 4.0 (0.4-44.1)
15+ 6/6 3.4 (0.6-17.9) 2/4 1.0 (0.1-11.0) 3/2 4.6 (0.5-46.9)
Comparison with siblings
Index birth 56/100 1.2 (0.8-1.8) 41/85 0.9 (0.6-1.5) 9/6 6.2 (1.3-29.8)
Immediately preceding birth 34/44 2.2 (1.1-4.4) 25/35 1.9 (0.9-4.2) 7/3 7.6 (0.9-63.9)
aEstimated using informative matched sets.
Table 8 Numbers of cases, controls and odds ratios (95% confidence interval)a by maternal illness, drug and radiographic exposures in pregnancy
Leukaemia
Total leukaemia Acute lymphoblastic Acute myeloid Non-Hodgkin's lymphoma
Cases/controls OR (95% Cl) Cases/controls OR (95% Cl) Cases/controls OR (95% Cl) Cases controls OR (95% Cl)
Total 143/286 113/226 15/30 34/68
Illnesses
Hypertensive disease 25/52 1.0 (0.6-1.6) 19/41 0.9 (0.5-1.7) 3/7 0.8 (0.2-3.7) 5/6 1.9 (0.5-7.4)
Albuminuria/proteinuria 13/19 1.4 (0.7-2.9) 11/15 1.5 (0.7-3.4) 0/4 0.0 (0.0-1.2) 4/6 1.3 (0.4-4.7)
Viral infection 6/2 6.0 (1.2-29.7) 4/2 4.0 (0.7-21.8) 0/0 - 2/0 o (1.2-)
Anaemia 17/15 2.4 (1.2-5.0) 11/10 2.3 (0.9-5.6) 4/3 3.3 (0.6-18.9) 3/6 1.0 (0.2-4.8)
Haemaglobin < 10 gb 11/6 3.8 (1.3-11.1) 5/2 4.6 (0.9-23.8) 4/3 3.3 (0.6-18.9) 1/5 0.3 (0.0-3.0)
Drugs
Antibiotics 8/19 0.8 (0.4-2.0) 5/15 0.7 (0.2-1.8) 1/0 (0.3-) 2/3 1.7 (0.1-21.1)
Anticonvulsants 4/4 2.0 (0.5-8.0) 3/2 3.0 (0.5-18.0) 0/1 0.0 (0.0-11.7) 2/3 1.4 (0.2-11.1)
Radiography
Any 32/72 0.8 (0.5-1.4) 25/47 1.1 (0.6-1.9) 3/13 0.0 (0.0-0.6) 9/21 0.8 (0.3-2.1)
Chest 17/34 1.0 (0.4-2.3) 11/12 2.3(0.8-6.1) 3/11 0.0(0.0-0.6) 3/10 0.4 (0.1-2.1)
Lower abdomen 16/43 0.7 (0.4-1.3) 15/36 0.8 (0.4-1.6) 0/4 0.0 (0.0-2.9) 6/12 1.0 (0.3-3.3)
Pelvimetry 9/12 1.6 (0.6-3.9) 8/10 1.6 (0.6-4.3) 0/2 0.0 (0.0-2.9) 3/3 2.0 (0.4-9.9)
aEstimated using informative matched sets. bper 100 ml.
and 0.4 (95% CI 0.1-2.0) for all leukaemias, acute lymphoblastic
leukaemia and acute myeloid leukaemia respectively. There is,
however, limited support for the proposition that the mothers of
leukaemic case children were more likely to have experienced
fertility problems, as can be seen more clearly in Table 4. At the
time of their first antenatal visit for the index pregnancy, 13 case
mothers and 13 control mothers reported undergoing fertility inves-
tigations ofsome kind (odds ratio 2.1; 95% CI 0.9-4.6). Ofthe five
cases and five controls treated specifically for the index pregnancy
(OR 2.0; 95% CI 0.6-6.9), four cases and three controls had
hormonal therapy (OR 2.7; 95% CI 0.6-11.9).
Information about the delivery and treatment of the neonates is
given in Table 5. The pattern offindings is different for leukaemia
and non-Hodgkin's lymphoma. At delivery, the 34 babies who
subsequently developed non-Hodgkin's lymphoma were more
likely than their corresponding controls to have been breech or
transverse lie (non-cephalic presentation) and to have been rela-
tively small,jaundiced and admitted to a special care nursery. Such
factors are, by their nature, strongly associated with each other -
small babies are more likely to be breech,jaundiced and in need of
special care. With such small numbers, disentangling relationships
is difficult, as can be seen from Table 6 in which the adjusted odds
ratios for non-cephalic presentation,jaundice, low birthweight and
admission to a special care nursery are given. With the exception
oflow birthweight, adjustment ofthe crude odds ratio forpotential
confounding factors moved the risks closer to unity. Indeed, as
might be anticipated, the adjusted odds ratio for admission to a
special care nursery reverted to 1.0 (95% CI 0.2-5.4) when presen-
tation,jaundice and low birthweight were taken into account.
In contrast to the 34 babies who developed non-Hodgkin's
lymphoma later in life, the 143 babies who developed leukaemia
in childhood or early adulthood did not appear to be particularly
disadvantaged at birth (Table 5). This lack of association is espe-
cially important for drugs given in labour, neonatal jaundice,
phototherapy and neonatal administration of intramuscular
vitamin K, all of which have been suggested as risk factors for
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Table 9 Details of cases and controls whose mothers were diagnosed with a viral infection during pregnancy
Infection
Decade of birth Age at diagnosis Sex Birthweight Diagnosis Gestation at diagnosis
(5-year group) (g) (weeks)
Acute lymphoblastic leukaemia 1970-79 0-4 M 3400 Influenza 15
5-9 M 2880 Influenza 13
5-9 F 3542 Vulval warts 17
1980-89 0-4 M 3215 Influenza 6
Other/unspecified leukaemia 1960-69 5-9 M 3940 Herpes simplex 24
1970-79 0-4 M 3490 Rubella 16
Non-Hodgkin's lymphoma 1970-79 5-9 M 3190 Chicken pox 34
1980-89 5-9 F 3095 Vulval warts 19
Controls 1970-79 - M 3870 Influenza 12
- F 4000 Influenza 12
Table 10 Details of cases and controls whose mothers had at least one recorded haemoglobin below 10 gb during pregnancy
Gestational age in weeks at
Decade Age at diagnosis Sex Birthweight Lowest Oral iron Parenteral Tranfusion Bone marrow
of birth (5-year group) (g) haemoglobin (g)b prescribeda iron biopsy
Acute lymphoblastic 1950-59 25-29 M 3800 38 (9.2) - 38 38 38
leukaemia 1960-69 0-4 F 3540 28 (9.6) 28 - - -
5-9 F 3460 36 (9.9) 36 - - -
1970-79 5-9 M 3290 36 (9.8) - - - -
5-9 M 4860 26 (8.6) 26 - - -
Acute myeloid leukaemia 1950-59 10-14 F 4140 35 (8.9) 35 37 37 -
1960-69 15-19 M 3910 35 (9.9) 22 - 37 37
15-19 F 4080 36 (9.6) 36 38 - -
1970-79 5-9 F 3925 39 (9.4) - - - -
Other/unspecified 1950-59 20-24 F 3570 8 (8.8) -
leukaemia 1960-69 0-4 M 3825 39 (9.8) - 39
Controls 1950-59 - F 2350 11 (9.8) 11 - - -
- M 3430 26 (9.7) 26 - - -
1960-69 - F 4140 32 (8.1) 16 - - -
1970-79 - F 3210 36 (9.5) 36 - - -
1980-89 - M 3445 23 (9.8) 23 - - -
- M 1200 25 (9.4) - - 25 -
aWith or without folic acid. bPer 100 ml.
leukaemia in general and acute lymphoblastic leukaemia inpartic-
ular. Indeed, for the leukaemias, the only statistically significant
associations were in the acute myeloid group, in which increased
risks were found for caesarean section (OR00; 95% CI 1.2-o) and
for birthweights of more than 3500 g (OR 6.2; 95% CI 1.3-29.8).
The finding for caesarean section is, however, based on only two
cases, one ofwhom weighed 3925 g at birth.
In the acute myeloid group, the average birthweights were
3615 g (standard error 107 g) and 3215 g (s.e. 84g) for cases and
controls respectively. Further information about the relation
between birthweight and leukaemia is presented in Table 7, which
shows the age-specific data and also a comparison between index
babies (cases and controls) and, for those whose mothers had a
previous birth, their immediately preceding siblings. Overall, for
age, the odds ratios tend to increase as age increases, but the trend
is not statistically significant (P = 0.06, for all leukaemias
combined). The findings forbirthweights ofpreceding siblings are
perhaps more intriguing: at 7.6 (95% CI0.9-63.9), the odds ratio
for birthweights of 3500 g or more among preceding siblings in
the acute myeloid group are of borderline statistical significance.
In addition, there is some suggestion that the preceding siblings of
children diagnosed with acute lymphoblastic leukaemia were
heavier than the preceding siblings oftheircorresponding controls
(OR 1.9; 95% CI 0.9-4.2), contributing to the fact that the odds
ratio for all leukaemias combined was 2.2 (95% CI 1.1-4.4).
Information about maternal illnesses, radiography and drugs
prescribedduring pregnancy are presented in Table 8. Two notable
case-control differences were found for maternal illnesses during
pregnancy; the first being for viral infection and the second for
anaemia. In the leukaemia group, information about a viral infec-
tion during pregnancy was recorded in the notes of six case
mothers and two control mothers (OR 6.0; 95% CI 1.2-29.7) and,
for non-Hodgkin's lymphoma, in the notes of two case mothers
and no control mothers, yielding an odds ratio ofinfinity (95% CI
1.2-c). Further information on the eight infections in the mothers
of case children and the two infections in the mothers of control
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children are listed in Table 9. The mothers ofboth control children
were diagnosed with influenza, as were three ofthe mothers whose
children went on to develop acute lymphoblastic leukaemia. Ofthe
remaining five cases, two of their mothers had vulval warts, one
had herpes simplex, one had rubella and one had chicken pox. All
eight case children were under 8 years old when their disease was
diagnosed, and the gestational ages at in utero infection ranged
from 6 to 34 weeks. Furthermore, although the numbers are
small, it may be worth noting the sexes of the affected children:
only two were female (both of whose mothers had genital warts),
a male-female sex ratio of 3.0.
Seventeen mothers of leukaemic children and 15 mothers of
control children (Table 8) were diagnosed with anaemia during the
index pregnancy (OR 2.4; 95% CI 1.2-5.0). Of those so diag-
nosed, 11 cases and six controls had at least one haemoglobin
below 10 g (OR 3.8; 95% CI 1.3-11.1). No association with non-
Hodgkin's lymphoma and anaemia is evident. Further information
about the 17 mothers and children in the leukaemic group (11
cases and six controls) with haemaglobins below 10 g is presented
in Table 10. Details about therapy for anaemia were recorded in
the notes of 9 (82%) of the 11 cases and all five of the controls:
three case mothers and one control mother were transfused, and
two of the transfused case mothers had a bone marrow biopsy.
Despite their mothers' anaemia, the leukaemic case babies
appeared remarkably healthy, with birthweights ranging from
3290 g to 4860 g (mean 3854 g). Two notable features of the
leukaemic cases are the female preponderance (male-female sex
ratio 0.8) and their comparatively late age at diagnosis: the odds
ratios increase from 1.3 (95% CI 0.2-8.0, based on two cases and
three controls) under 5 years ofage to 3.9 (95% CI 0.7-20.9, based
on five cases and three controls) at 5-14 years and reach infinity
(based on four cases and no controls) at 15 years of age or more
(test for trend with age; Z = 3.6, P < 0.01).
No other statistically significant associations were found for
exposures during pregnancy, although the findings for anticonvul-
sant usage and pelvimetry are similar to those that have been
reported before (Table 8). In addition to the data given in Table 8,
information about a range of other drugs and vitamins were
recorded in the hospital notes; all were examined and no statisti-
cally significant associations were found. The findings are not
presented here because the numbers of subjects were often small,
and there was considerable overlap between the exposures - some
women having several drugs listed while the majority had none at
all. In view of the findings for anaemia, however, it is notable that
no case-control differences with respect to the prescription of iron
and/or folic acid were apparent.
DISCUSSION
The investigation described here was specifically designed to
examine the relation between prenatal and neonatal factors and the
subsequent development of haematological malignancies in chil-
dren and young adults, its success depending on the ability to link
routinely collected cancer registration data with good quality
obstetric information. While the results presented here could have
been affected by chance because of small numbers, we believe that
they are unlikely to have been biased; information about exposure
was abstracted from records compiled before diagnosis, and the
'find' rate for obstetric records was high at 85%. Inspection of the
delivery records of case and control babies whose mother's
obstetric notes could not be traced, revealed nothing unusual (data
not shown), making it unlikely that the obstetric records of
subjects whose notes we could not find differed in important
respects from those we could. Further, although the four research
nurses (three midwives and one paediatric nurse) who traced and
abstracted the medical notes were not 'blind' to case-control
status, great care was taken to ensure that such knowledge did not
result in biased data collection; the tightly structured abstraction
forms and coding procedures were designed and tested before the
study began, andcross-checks in the form ofduplicate abstractions
and coding were used for initial training and periodically
throughout for quality control.
The study does, however, have certain weaknesses, although it is
not clear how our findings would have been influenced by them.
Some individuals diagnosed with cancer who were born within the
catchment areas of the study hospitals (or their predecessors) in the
years for which obstetric data were being obtained will have been
missed, either because their NHS number was not added to the
cancer registration databases or because their cancer was not regis-
tered in the national scheme. Estimating this shortfall with any
degree of accuracy is not possible as reliable cancer registration
data are not available for the earlier years and annual tallies of
births were not kept at the study hospitals. Further, while we know
that the controls were alive and had no serious anomalies diagnosed
before discharge and that they did not have a cancer registration
with an NHS number attached, we cannot be certain that they were
alive and cancer free when their corresponding case was diagnosed.
Characteristics of the baby and neonatal exposures
There is strong evidence that certain genetic conditions predispose
towards malignancy in later life, male sex and Down's syndrome
being well-recognized risk factors for childhood leukaemia for
example Doll (1989). In the present study, cases and controls were
matched on sex, and babies with chromosomal anomalies were
excluded as these variables would have acted as strong
confounders in many of the analyses.
A number of investigators have reported that heavy birthweight
is a risk factor for childhood leukaemia (MacMahon and Newill,
1962; Fasal et al, 1971; Wertelecki and Mantel, 1973; Shu et al,
1988; Kaye et al, 1991; Cnattingius et al, 1995; Ross et al, 1996),
although others have found no such relation (McKinney et al,
1987; Golding et al, 1990; Zack et al, 1991). Most studies to date
have concentrated either on infants or on children diagnosed
before the age of 15 years, some concluding that the association
between birthweight and leukaemia is strongest for younger ages,
some that it is more pronounced for acute lymphoblastic
leukaemia and some that the birthweight effect predominates in
one sex or the other (for review see Ross et al, 1996).
On balance, our findings support the view that factors associ-
ated with fetal growth may also be associated with the subsequent
development of leukaemia, particularly of the acute myeloid type
in which a sixfold increase in risk was found for babies weighing
more than 3500 g. However, no statistically significant trends with
age at diagnosis were detected for all leukaemias combined or for
acute lymphoblastic leukaemia alone, and examination of our data
for men and women separately did not reveal any systematic
differences (data not shown). Further, the observation that older
siblings of leukaemic children were also comparatively heavy at
birth cautions against ascribing a direct causal link between birth-
weight and leukaemia, the inference being that other factor(s)
could be responsible for both phenomena.
British Journal ofCancer(1997) 76(3), 406-415 0 CancerResearch Campaign 1997Pre- and neonatal factors in leukaemia and NHL 413
As well as having relatively high birthweights, the leukaemic
cases appeared comparatively robust at birth with respect to other
indicators of well-being, the odds ratios for jaundice,
phototherapy, admission to special care nursery and neonatal
intensive care all being less than 1.0. Although the numbers are
small, it should be noted that our findings for phototherapy agree
with those of Cnattigius and colleagues (1995), offering little
support for the hypothesis that neonatal exposure to strong illumi-
nation is a material cause of acute lymphoblastic leukaemia (Ben-
Sasson and Davis, 1992).
The lack of an association between leukaemia and administra-
tion of intramuscular vitamin K to the neonate also deserves
particular attention as, after the report of Golding and colleagues
in 1992, this issue has been the subject of considerable debate
(Draper and Stiller, 1992; Ekelund et al, 1993; Olsen et al, 1994;
Ansell et al, 1996; von Kreis et al, 1996; Zipursky et al, 1996). The
retrospective assessment ofwhether a baby received vitamin K and
by what route is not straightforward (Ansell et al, 1996) and,
because of this, we presented our results in two ways, firstly by
what was recorded in the notes and secondly by what could be
imputed about hospital policy. With either method, our findings
do not support the suggestion of an association between intra-
muscular vitamin K and leukaemia. In a recent report von Kreis
and colleagues (1996) presented data on acute lymphoblastic
leukaemia for children aged between the ages of one and six years
calculating an adjusted odds ratio for administration of intra-
muscular vitamin K of 1.2 (95% CI 0.7-2.2). For comparative
purposes, our data for the same disease group and age range
produced an odds ratio of 0.6 (95% CI 0.3-1.4) based on hospital
notes and 0.6 (95% CI 0.2-1.7) based on hospital policy; adjust-
ment for potential confounders, such as admission to a special care
nursery and mode of delivery, had no material effect.
Relatively little obstetric data has been published for non-
Hodgkin's lymphoma, and the present report only contains infor-
mation on 34 cases. McKinney and colleagues (1987) studied 31
children with non-Hodgkin's lymphoma and found that they were
significantly lighter at birth than their corresponding controls. As
we also found that at birth the non-Hodgkin's lymphoma cases
appeared generally disadvantaged (although not significantly so)
by comparison with their own controls, and by comparison with
the leukaemic cases, further research on the relation between
prenatal and neonatal factors and non-Hodgkin's lymphoma may
be warranted.
In utero exposures
The suggestion that in utero exposure to viral infection, particu-
larly influenza and varicella, may predispose towards leukaemia is
not new, although the evidence is inconsistent (Stewart et al, 1958;
Adelstein and Donovan, 1972; Fedrick and Alberman, 1972; Leck
and Steward, 1972; Doll, 1973; Hakulinen et al, 1973; Fine et al,
1985; McKinney et al, 1987; Gilman et al, 1989; Anon, 1990;
Ross et al, 1994). Taken at face value, the approximately sixfold
increased risk found here supports the hypothesis that prenatal
viral infection may be related to the subsequent development of
not only childhood leukaemia (six cases and two controls) but also
of childhood non-Hodgkin's lymphoma (two cases and no
controls). However, as with birthweight, this finding should not
necessarily be taken to imply a direct causal relation as the docu-
mented exposures relate to the manifestation of clinically diag-
nosed maternal viral disease and not to documented fetal exposure
to a viral infection. Unfortunately, information about whether the
two cases of vulval warts and the one case of herpes simplex were
incident cases (diagnosed for the first time in the index pregnancy)
or were severe eruptions of a pre-existing condition were not
recorded in the notes.
As far as we are aware, the possibility that maternal anaemia in
pregnancy may be related to leukaemia has not been suggested
before, although data contained within a report on the Oxford
Survey of Childhood Cancers show a positive association between
anaemia and all cancers combined (Gilman et al, 1989). A striking
feature of our data is the difference between the ages and sexes of
the leukaemias associated with anaemia in pregnancy and those
associated with viral infection: the former being predominantly
older female cases and the latter younger male cases. As with the
findings for birthweight and viral infection, however, the meaning
of the almost fourfold increase in risk associated with a maternal
haemoglobin below 10 g is unclear. Although it is possible that
lack of a nutrient while in utero, such as iron or folate, could
predispose towards leukaemia, it is also possible that the mother's
anaemia and the offspring's leukaemia could, in fact, share a
common cause.
Apart from viral infection and anaemia, there was little support
within our data for associations between leukaemia and maternal
use of anticonvulsants or antibiotics during pregnancy or with
drugs given to the mother in labour, the odds ratios for anaesthetics,
entonox and pethidine all being close to unity (Doll, 1973; Kinnier-
Wilson et al, 1981; McKinney et al, 1985; Robison et al, 1988;
Gilman et al, 1989; Golding et al, 1990; Cnattingius et al, 1995).
Maternal characteristics and birth order
A number of investigators have suggested that certain characteris-
tics of the mother could predispose towards leukaemia in her
offspring. This is a complex area as disentangling relationships
between a mother's prior reproductive history, her age and the
birth order of the affected child is not straightforward.
Although some researchers have found an association with
advanced maternal age (Stewart et al, 1958; MacMahon and
Newill, 1962; Stark and Mantel, 1966; Shaw et al, 1984; Kaye et
al, 1991), others have not (Fasal et al, 1971; Salonen, 1976; van
Steensel-Moll et al, 1985; McKinney et al, 1987; Shu et al, 1988;
Golding et al, 1990, 1992; Kaye et al, 1991; Zack et al, 1991;
Cnattingius et al, 1995). Similarly, while it has been suggested that
being the first-born child may be a risk factor for leukaemia
(MacMahon and Newill, 1962; Stark and Mantel, 1966; van
Steensel-Moll et al, 1986; MacMahon, 1992), many studies have
failed to confirm this association (Fasal et al, 1971; Salonen, 1976;
Shaw et 1984; McKinney et al, 1987; Shu et al, 1988; Golding et
al, 1990, 1992; Kaye et al, 1991; Zack 1991; Zack et al, 1991;
Roman et al, 1994; Cnattingius et al, 1995). Likewise, although it
has been hypothesized that mothers of leukaemic children are
more likely to have had prior fetal deaths and have fertility prob-
lems (van Steensel-Moll et al, 1985), the evidence is sparse and
contradictory (MacMahon and Newill, 1962; Shu et al, 1988; Kaye
et al, 1991; Cnattingius et al, 1995)
We found no evidence of any link between leukaemia and birth
order, but our findings with respect to maternal age, numbers of
previous pregnancies and fertility treatment highlight the
complexity of the issues - the mothers of leukaemic cases being
marginally older, having slightly fewer past pregnancies and being
more likely to have had fertility treatment than their corresponding
British Journal ofCancer (1997) 76(3), 406-415 0 Cancer Research Campaign 1997414 ERomanetal
controls. None of the differences were statistically significant, but
in view ofcurrent trends with respect to fertility treatment this area
may warrant further research.
CONCLUSION
The findings presented here contribute to the accumulating body
of knowledge about possible prenatal origins of haematological
cancers. The methods and procedures used proved to be reliable,
and the investigation has now been extended to include other
malignancies and other hospitals.
While some hypotheses were supported by our analyses (e.g. in
utero viral exposure), others were not (e.g. neonatal vitamin K). In
addition, novel associations that require confirmation in future
research have emerged (e.g. maternal anaemia in pregnancy).
Information on larger numbers ofcases incorporating more refined
diagnostic and biological information are clearly required. For
children diagnosed before the age of 15 years, this should be
provided by the United Kingdom Childhood Cancer Study
(UKCCS), which is a collaborative study of several thousand chil-
dren diagnosed with cancer in the UK. Our findings suggest,
however, that prenatal factors may be important determinants of
haematological malignancies in young adults, as well as in chil-
dren. Given that the clearest example to date of an in utero expo-
sure causing cancer is that of maternal diethylstilboestrol use in
pregnancy and clearcell adenocarcinoma in young women (Herbst
et al, 1971), and considering the suggestions that testis cancer
(Swerdlow et al, 1987) and breast cancer (Ekbom et al, 1992;
Michels et al, 1996) may have a prenatal component to their aeti-
ology, this is perhaps not unexpected.
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